Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin + misoprostol versus carbetocin for reducing blood loss at caesarean section
PACTR202201742377791Completed
- Sponsor
- sofiat ayobami yusuf
- Start
- Jul 2021
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in postpartum hemorrhage (PPH) comparing Oxytocin + misoprostol combination with Carbetocin (2 arms). Primary endpoints: Efficacy in reducing blood loss at caesarean section, Average blood loss at surgery and 1 more. Started Jul 2021; status: completed.
02
Drugs
carbetocinoxytocinmisoprostol
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on PACTR202201742377791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202201742377791.